BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20077513)

  • 1. Graphical displays for clarifying how allocation ratio affects total sample size for the two sample logrank test.
    Saville BR; Kim YS; Koch GG
    Pharm Stat; 2011; 10(1):40-4. PubMed ID: 20077513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size determination for comparing several survival curves with unequal allocations.
    Halabi S; Singh B
    Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size determination in step-up testing procedures for multiple comparisons with a control.
    Kwong KS; Cheung SH; Wen MJ
    Stat Med; 2010 Nov; 29(26):2743-56. PubMed ID: 20799258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimates, power and sample size calculations for two-sample ordinal outcomes under before-after study designs.
    Strickland PA; Lu SE
    Stat Med; 2003 Jun; 22(11):1807-18. PubMed ID: 12754716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential boundaries approach in clinical trials with unequal allocation ratios.
    Jafari P; Ayatollahi SM; Behboodian J
    BMC Med Res Methodol; 2006 Jan; 6():1. PubMed ID: 16412232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size calculation in survival trials accounting for time-varying relationship between noncompliance and risk of outcome event.
    Li B; Grambsch P
    Clin Trials; 2006; 3(4):349-59. PubMed ID: 17060209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sample size and optimal designs in stratified comparative trials to establish the equivalence of treatment effects among two ethnic groups.
    Chen YH; Wang M
    J Biopharm Stat; 2002 Nov; 12(4):553-66. PubMed ID: 12477074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size re-estimation in group-sequential response-adaptive clinical trials.
    Morgan CC
    Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size for two-stage studies with maintenance therapy.
    Feng W; Wahed AS
    Stat Med; 2009 Jul; 28(15):2028-41. PubMed ID: 19382105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing sample size formulae for trials with unbalanced allocation using the logrank test.
    Hsieh FY
    Stat Med; 1992 Jun; 11(8):1091-8. PubMed ID: 1496196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimum sample size allocation to minimize cost or maximize power for the two-sample trimmed mean test.
    Guo JH; Luh WM
    Br J Math Stat Psychol; 2009 May; 62(Pt 2):283-98. PubMed ID: 18157920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size planning with the cost constraint for testing superiority and equivalence of two independent groups.
    Guo JH; Chen HJ; Luh WM
    Br J Math Stat Psychol; 2011 Nov; 64(3):439-61. PubMed ID: 20704777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
    Jiang H; Symanowski J; Paul S; Qu Y; Zagar A; Hong S
    Stat Med; 2008 Dec; 27(28):5850-60. PubMed ID: 18759373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Power of pairwise comparisons in the equal variance and unequal sample size case.
    Ramsey PH; Ramsey PP
    Br J Math Stat Psychol; 2008 May; 61(Pt 1):115-31. PubMed ID: 18482478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal sample sizes for Welch's test under various allocation and cost considerations.
    Jan SL; Shieh G
    Behav Res Methods; 2011 Dec; 43(4):1014-22. PubMed ID: 21512873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple procedure to compute the sample size needed to compare two independent groups when the population variances are unequal.
    Singer J
    Stat Med; 2001 Apr; 20(7):1089-95. PubMed ID: 11276038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample sizes required to detect two-way and three-way interactions involving slope differences in mixed-effects linear models.
    Heo M; Leon AC
    J Biopharm Stat; 2010 Jul; 20(4):787-802. PubMed ID: 20496206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graphical approaches to the analysis of safety data from clinical trials.
    Amit O; Heiberger RM; Lane PW
    Pharm Stat; 2008; 7(1):20-35. PubMed ID: 17323410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On design considerations and randomization-based inference for community intervention trials.
    Gail MH; Mark SD; Carroll RJ; Green SB; Pee D
    Stat Med; 1996 Jun; 15(11):1069-92. PubMed ID: 8804140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blinded sample size recalculation in multicentre trials with normally distributed outcome.
    Jensen K; Kieser M
    Biom J; 2010 Jun; 52(3):377-99. PubMed ID: 20394080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.